迪沙藥業(yè)連續(xù)8年蟬聯(lián)中國(guó)醫(yī)藥工業(yè)百強(qiáng)
發(fā)布時(shí)間：
2022-11-16
作者：
由中國(guó)醫(yī)藥工業(yè)信息中心主辦的2018年（第35屆）全國(guó)醫(yī)藥工業(yè)信息年會(huì)在上海盛大開幕，大會(huì)隆重發(fā)布了備受行業(yè)關(guān)注的2017年度中國(guó)醫(yī)藥工業(yè)百強(qiáng)企業(yè)榜單，迪沙藥業(yè)再次榮登百強(qiáng)榜，連續(xù)8年蟬聯(lián)中國(guó)醫(yī)藥工業(yè)百強(qiáng)。
根據(jù)中國(guó)醫(yī)藥工業(yè)信息中心的統(tǒng)計(jì)和分析，2017年度百強(qiáng)榜上榜企業(yè)延續(xù)了一貫的強(qiáng)勁增長(zhǎng)動(dòng)力，以主營(yíng)業(yè)務(wù)收入10.2%的增速突破7,500億大關(guān)，雖然增速較上年同期下降0.9個(gè)百分點(diǎn)，但增長(zhǎng)趨勢(shì)仍基本保持平穩(wěn)。值得注意的是，百強(qiáng)榜門檻也由去年的24.4億元提升至25.6億元，小幅提升5%。在百強(qiáng)企業(yè)的龍頭帶動(dòng)作用下，醫(yī)藥產(chǎn)業(yè)正逐步邁向規(guī)模經(jīng)濟(jì)。
迪沙藥業(yè)始建于1993年，位于譽(yù)滿全球的生態(tài)宜居之城——威海，歷經(jīng)20余載風(fēng)雨兼程、披荊斬棘，漸已發(fā)展成為傳奇威海、屹立齊魯、馳名中國(guó)、走向世界的制藥強(qiáng)企。集團(tuán)是產(chǎn)學(xué)研相結(jié)合、科工貿(mào)一體化的國(guó)家重點(diǎn)高新技術(shù)企業(yè)，經(jīng)過20多年發(fā)展，現(xiàn)已形成制劑、綠色高科技原料藥、海洋生物健康產(chǎn)業(yè)3大業(yè)務(wù)板塊，建成西藥制劑、原料藥、中藥、海洋生物新材料、海洋生物健康產(chǎn)品五大生產(chǎn)基地。2017年實(shí)現(xiàn)銷售收入36億元，連續(xù)8年入選中國(guó)醫(yī)藥工業(yè)百強(qiáng)企業(yè)。
迪沙藥業(yè)集團(tuán)有限公司培養(yǎng)基供應(yīng)商：青島日水生物
China Pharmaceutical Industry Information Center (CMIC) sponsored the opening of the National Medicinal Industry Information Annual Meeting in Shanghai in 2018. The meeting solemnly released the list of the top 100 enterprises in China's pharmaceutical industry in 2017, which attracted the attention of the industry. Disha Pharmaceutical Industry was once again ranked the top 100 enterprises in China's pharmaceutical industry for eight consecutive years.
According to the statistics and analysis of the China Pharmaceutical Industry Information Center, the enterprises listed on the Top 100 list in 2017 continued their strong growth momentum, breaking through 750 billion yuan mark with the growth rate of 10.2% of the main business income. Although the growth rate decreased by 0.9 percentage points compared with the same period last year, the growth trend remained basically stable. It is worth noting that the top 100 threshold also increased from 2 billion 440 million yuan last year to 2 billion 560 million yuan, a slight increase of 5%. Under the leading role of top 100 enterprises, the pharmaceutical industry is gradually moving towards scale economy.
Disha Pharmaceutical Co., Ltd. was founded in 1993. It is located in Weihai, an ecologically livable city with a global reputation. The group is a national key high-tech enterprise which integrates production, learning and research, science, industry and trade. After more than 20 years of development, it has formed three major business sectors: preparations, green high-tech raw materials, marine biological health industry, and has built five major students: western medicine preparations, raw materials, traditional Chinese medicine, new marine biological materials and marine biological health products. Production base. In 2017, the sales revenue reached 3 billion 600 million yuan and was selected into top 100 enterprises in China's pharmaceutical industry for 8 consecutive years.